The Effect of The Combination Therapy of Statin and SGLT2i in The Treatment of Ischemic Heart Disease
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY
correlate the serum level of statin and SGLT2i when given as polytherapy with HPLC in ischemic heart failure patients and their laboratory tests (cholesterol, LDL, HDL and TG...)
Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Maximum Age: 80
View:
• we include patients established ischemic heart failure seen by a primary care provider to diagnose ischemic heart disease,
• They assessed the use of statin with SGLT2i.
Locations
Other Locations
Egypt
Asmaa mohamed abdelkader
RECRUITING
Al Fayyum
Contact Information
Primary
Raghda Roshdy
Raghda.hussien@pharm.bsu.edu.eg
01010647666
Backup
Marwa Kamal
mka05@fayoum.edu.eg
01067789982
Time Frame
Start Date: 2024-06-01
Estimated Completion Date: 2025-12-30
Participants
Target number of participants: 90
Treatments
Patients has ischemic heart failure
30 patients will take statin.
Patients has ischemic heart
30 patients will take both of statin and SGLT2i.
Patients has heart disease
30 patients will take SGLT2i.
Related Therapeutic Areas
Sponsors
Leads: Fayoum University